Kineret (anakinra) reduces the actions of chemicals in the body that are involved in inflammatory and immune responses.
Kineret is used to treat the symptoms of moderate to severe rheumatoid arthritis in adults. Kineret may also help slow the progress of the disease. This medicine is usually given after other arthritis medications did not work or have stopped working.
Kineret is also used in newborn babies to treat a rare genetic condition called neonatal onset multisystem inflammatory disease (NOMID). NOMID is a form of cryopyrin-associated periodic syndromes (CAPS). This condition causes uncontrolled inflammation in many parts of the body, including the skin, joints, and central nervous system.
Kineret is also used to control symptoms of a condition called Deficiency of Interleukin-1 Receptor Antagonist (DIRA) in adults and children. DIRA is a very rare genetic condition that causes a severe inflammatory reaction during the first days of life and can lead to organ failure throughout the body.
